Bristol Myers Squibb gets European Commission nod for Breyanzi for follicular lymphoma Ruchika Sharma16 March 2025 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi (lisocabtagene...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
USFDA grants accelerated approval for Bristol Myers Squibb CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma Ruchika Sharma16 May 2024 2:30 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
Roche gets USFDA nod for Columvi to treat relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma18 Jun 2023 2:42 PM ISTColumvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.
Roche bags USFDA approval for Lunsumio to treat follicular lymphoma Ruchika Sharma24 Dec 2022 2:00 PM ISTFollicular lymphoma (FL) is the most common slow-growing (indolent) form of non-Hodgkin lymphoma, accounting for about one in five cases.
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Roche gets USFDA priority review for Lunsumio to treat relapsed or refractory follicular lymphoma Ruchika Sharma8 July 2022 5:30 PM ISTPriority Review designation is granted to medicines that the FDA considers to have the potential to provide significant improvements in the safety and...
Novartis Kymriah gets USFDA nod for relapsed or refractory follicular lymphoma Ruchika Sharma30 May 2022 12:19 PM IST"Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings," claims the...
Gilead Sciences withdraws use of Zydelig for 2 types of cancer Ruchika Sharma16 Jan 2022 11:00 AM ISTNew Delhi: Gilead Sciences Inc on Friday notified the U.S. health regulator of its decision to voluntarily withdraw the use of its drug Zydelig...
Novel Therapy safe for Non-Hodgkin Lymphoma Patients, finds study Hina Zahid10 Dec 2020 11:29 AM ISTBUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center's Francisco J. Hernandez-Ilizaliturri, MD, along with a team of researchers from other...
